Skip to main content
All lobbying filings

VAN SCOYOC ASSOCIATES

Lobbying for AMERICAN HERBAL PRODUCTS ASSOCIATION

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

Hemp-Derived Cannabidiol (CBD) regulations and legislation Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.7366, Dietary Supplement Regulatory Uniformity Act, Entirety H.R.7407, Prohibiting Tianeptine and Other Dangerous Products Act of 2026, Entirety H.R.10336, Dietary Supplement Innovation Act, Entirety

Monitor Herbal and botanical products, Tariff policy related issues

H.R.8933/S.4587, Dietary Supplements Access Act, Entirety

 Bills named in this filing 5
  • H.R. 7366
    Dietary Supplement Regulatory Uniformity Act
  • H.R. 7407
    Prohibiting Tianeptine and Other Dangerous Products Act of 2026
  • H.R. 10336
    Dietary Supplement Innovation Act
  • H.R. 8933
    Dietary Supplements Access Act
  • S. 4587
    Dietary Supplements Access Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem